Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A known ✓ | P08913 | 4/20 | 0.45 |
| ▸ | ADRA2B known ✓ | P18089 | 4/20 | 0.45 |
| ▸ | ADRA2C known ✓ | P18825 | 4/20 | 0.45 |
| ▸ | ADRA1D known ✓ | P25100 | 3/20 | 0.45 |
| ▸ | ADRA1A known ✓ | P35348 | 3/20 | 0.45 |
| ▸ | ADRA1B known ✓ | P35368 | 3/20 | 0.45 |
| ▸ | DRD2 | P14416 | 2/20 | 0.60 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.46 |
| ▸ | DRD1 | P21728 | 1/20 | 0.43 |
| ▸ | DRD5 | P21918 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | ESR1 | P03372 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | G6PD | P11413 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL239049 | 1.00 | DRD2 (0.60) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| Bromide SCHEMBL240352 | 1.00 | DRD2 (0.60) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| Bromide SCHEMBL240587 | 1.00 | DRD2 (0.60) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| SCHEMBL7874803 | 0.98 | DRD2 (0.61) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| SCHEMBL7886601 | 0.98 | DRD2 (0.61) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| SCHEMBL7880605 | 0.98 | DRD2 (0.61) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| SCHEMBL7875415 | 0.98 | DRD2 (0.61) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| Bromide SCHEMBL253554 | 0.91 | DRD2 (0.74) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| Bromide SCHEMBL252775 | 0.91 | DRD2 (0.74) | DRD2HSD11B1ADRA2AADRA2BADRA2C | |
| Bromide SCHEMBL237610 | 0.91 | DRD2 (0.74) | DRD2HSD11B1ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120196889-A1 | CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF | H. LUNDBECK A/S (DK) | 2012-08-02 | — | — | US | disclosed |
| EP-2401255-A1 | CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF | H. Lundbeck A/S (DK) | 2012-01-04 | — | — | EP | disclosed |
| WO-2010097087-A1 | CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF | H. LUNDBECK A/S (DK) | 2010-09-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196889-A1 | CATECHOLAMINE DERIVATIVES AND PRODRUGS THEREOF | COMT, ADRB3, ADRB1 | ADRA2A 9/4885ADRA2B 7/4885ADRA2C 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.